Role of CD39 in COVID-19 Severity: Dysregulation of Purinergic Signaling and Thromboinflammation

被引：0
|
作者：
Alfaro, E. [1 ]
Diaz-Garcia, E. [2 ]
Garcia-Tovar, S. [1 ]
Zamarron, E. [3 ]
Mangas, A. [4 ]
Galera, R. [4 ]
Ruiz-Hernandez, J. [5 ]
Sole-Violan, J. [5 ]
Rodriguez-Gallego, C. [5 ]
Van-Den-Rym, A. [6 ]
Perez-De-Diego, R. [6 ]
Nanwani-Nanwani, K. [7 ]
Lopez-Collazo, E.
Garcia-Rio, F. [4 ]
Cubillos, C. [8 ]
机构：
[1] Univ Paz, Grp Enfermedades Resp, Inst Invest, Biomed Hosp, Madrid, Spain
[2] CIBERES, Grp Enfermedades Resp, Madrid, Spain
[3] Hosp Univ La Paz, Dept Neumologia, Madrid, Spain
[4] Hosp Univ La Paz, Dpto Neumol, Madrid, Spain
[5] Hosp Univ Dr Negrin, Dpto Inmunol, Las Palmas Gran Canaria, Spain
[6] Univ La Paz, Lab Immunogenet Human Dis, Inst Invest, Biomed Hosp, Madrid, Spain
[7] Hosp Univ La Paz, Dpto Med Intensiva, Madrid, Spain
[8] Univ La Paz, Grp Respuesta Inmune Innata, Inst Invest, Biomed Hosp, Madrid, Spain
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2747
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The Role of CD39 in Ovarian Cancer
    Brauneck, F.
    Witt, M.
    Oliveira-Ferrer, L.
    Sturmheit, T.
    Bokemeyer, C.
    Menzel, S.
    Fiedler, W.
    Wellbrock, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 72 - 72
  • [22] LIMITED TCR REPERTOIRE AND ABERRANT CD39 REGULATION MARK LATE-STAGE COVID-19
    Wang, Na
    Vuerich, Marta
    Kalbasi, Ahmadreza
    Shaefi, Shahzad
    Robson, Simon C.
    Longhi, Maria Serena
    HEPATOLOGY, 2021, 74 : 47A - 47A
  • [23] CONJUGATION OF HUMAN RECOMBINANT CD39 TO PRIMARY HUMAN HEPATOCYTES PROTECTS AGAINST THROMBOINFLAMMATION
    Asif, Sana
    Jonsson, Nina
    Teramura, Yuji
    Gustafson, Elisabet
    Ekdahl, Kristina N.
    Nilsson, Bo
    TRANSPLANTATION, 2015, 99 (11) : S140 - S140
  • [24] Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer
    Kuenzli, Beat M.
    Bernlochner, Maria-Isabell
    Rath, Stephan
    Kaeser, Samuel
    Csizmadia, Eva
    Enjyoji, Keiichi
    Cowan, Peter
    d'Apice, Anthony
    Dwyer, Karen
    Rosenberg, Robert
    Perren, Aurel
    Friess, Helmut
    Maurer, Christoph A.
    Robson, Simon C.
    PURINERGIC SIGNALLING, 2011, 7 (02) : 231 - 241
  • [25] Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer
    Beat M. Künzli
    Maria-Isabell Bernlochner
    Stephan Rath
    Samuel Käser
    Eva Csizmadia
    Keiichi Enjyoji
    Peter Cowan
    Anthony d’Apice
    Karen Dwyer
    Robert Rosenberg
    Aurel Perren
    Helmut Friess
    Christoph A. Maurer
    Simon C. Robson
    Purinergic Signalling, 2011, 7 : 231 - 241
  • [26] Conjugation of human recombinant CD39 to primary human hepatocytes protects against thromboinflammation
    Asif, Sana
    Jonsson, Nina
    Teramura, Yuji
    Gustafson, Elisabet
    Ekdahl, Kristina N.
    Nilsson, Bo
    XENOTRANSPLANTATION, 2015, 22 : S87 - S87
  • [27] Severe COVID-19 disease and thromboinflammation
    Jerjes-Sanchez, Carlos
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2020, 90 (03): : 232 - 233
  • [28] Thromboinflammation response to tocilizumab in COVID-19
    Gergi, Mansour
    Cushman, Mary
    Littenberg, Benjamin
    Budd, Ralph C.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2020, 4 (08) : 1262 - 1268
  • [29] Purinergic signaling: decoding its role in COVID-19 pathogenesis and promising treatment strategies
    Zahra Shafaghat
    Amir-Hossein Khosrozadeh Ghomi
    Hossein Khorramdelazad
    Elaheh Safari
    Inflammopharmacology, 2023, 31 : 3005 - 3020
  • [30] Purinergic signaling: decoding its role in COVID-19 pathogenesis and promising treatment strategies
    Shafaghat, Zahra
    Ghomi, Amir-Hossein Khosrozadeh
    Khorramdelazad, Hossein
    Safari, Elaheh
    INFLAMMOPHARMACOLOGY, 2023, 31 (06) : 3005 - 3020
12345